Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Potential Hypertension Medication Poised to Reduce Risk of Blood-Pressure-Induced Dementia, Cognitive Decline
Lexaria Bioscience is a global innovator in drug delivery platforms that has developed the patented DehydraTECH(TM) technology for improved delivery of bioactive compoundsThe company is currently evaluating DehydraTECH-processed CBD as a potential treatment for high blood pressureLong-term studies have shown that high blood pressure can increase the risk of developing dementia in later lifeExperts, however, believe that hypertension medication could slow the pace of the…